PointClickCare

1.1 Identity, platform, and operating model

PointClickCare was founded in Mississauga in 2000 by brothers Dave and Mike Wessinger, initially as a clinical documentation tool for one long-term-care facility. The available profile evidence describes a later expansion across skilled nursing, assisted living, independent living, and home health, with products spanning electronic health records, medication management, billing, population health analytics, and care transitions. A separate company profile characterizes the business as a cloud-based EHR and care-coordination platform for senior and post-acute care. The company's own March 2026 release describes a next-generation EHR for practice groups with native AI workflow features and bi-directional exchange across PointClickCare and non-PointClickCare facilities. These sources support the identity and product model, but not a complete segment-level revenue split or a verified current valuation.[CO001, CO002, CO003, CO004]

1.2 Leadership, ownership, and capital

The evidence identifies Dave Wessinger as CEO and co-founder and Mike Wessinger as executive chair and co-founder, indicating meaningful founder continuity. An investor-profile source says Brian Gannon, formerly of TriNet, became CFO in December 2024; that change is a relevant maturity and governance signal, although the available evidence does not establish a full board roster, succession plan, or employment terms. The company is described as privately held, with Dragoneer Investment Group, Hellman & Friedman, and JMI Equity among its backers. A 2021 secondary investment is reported as valuing the company at approximately $18.4 billion, but this is a historical third-party report rather than a current mark. Current total raised, debt, preference terms, and any confirmed IPO timetable remain unsupported in this pool.[CO002, CO005, CO006, CO007, CO008]

1.3 Scale, customers, and product expansion

PointClickCare's scale is visible primarily through operating-footprint disclosures rather than audited financial statements. The March 2026 company release says the platform is trusted by over 30,000 provider organizations. A 2025 trade report gives a more granular but different snapshot: more than 27,000 long-term and post-acute providers, 3,600 ambulatory clinics, 2,800 hospitals, 350 risk-bearing providers, and 70 state and government agencies. The same report says a separate analytics company served roughly 1,700 skilled nursing facilities, illustrating the scale of a data-access ecosystem but not PointClickCare revenue. The company also says its 2026 practice-group product embeds Ambient Scribe and clinical-prioritization tools; an early adopter reported saving five minutes per note, a customer statement rather than an independently measured outcome. The conflicting provider totals should be carried as period- and definition-sensitive rather than reconciled into one exact customer count.[CO009, CO010, CO011, CO012]

1.4 Milestones and material risks

The most material documented risk is the Real Time Medical Systems litigation over automated access to PointClickCare-hosted records. A Fourth Circuit case summary says the district court granted a preliminary injunction and that the appellate court affirmed, finding PointClickCare's conduct likely implicated information blocking and that the company had not shown an applicable exception. Trade coverage records PointClickCare's position that bots posed security and performance risks, while also reporting that the court record was preliminary and contested. This is a legal and platform-governance risk, not proof of a final liability judgment. The milestone record also includes the 2024 lawsuit filing, the 2025 appellate decision, the June 2025 renewed dismissal effort, and the March 2026 practice-group EHR launch. The pool does not establish a post-breach forensic report, current enforcement outcome, audited revenue, or a current valuation, so those remain explicit diligence gaps.[CO013, CO014, CO015, CO016]

1.5 Exhibits

2.1 Market boundary and customer economics

The relevant market is not all electronic health records. It is the software and connected-data spend of long-term and post-acute care providers, especially skilled nursing facilities and senior living operators, with adjacent demand from hospitals, health plans, pharmacies, and analytics partners that need post-acute information. PointClickCare's platform is described as combining clinical documentation, medication management, billing, analytics, and interoperability for this setting, which makes the core buying decision a workflow and system-of-record decision rather than a single-feature purchase. Included spend therefore covers the core EHR, revenue-cycle functions, care coordination, data exchange, analytics, and workflow add-ons. Excluded from the core boundary are acute-care enterprise EHRs, standalone clinical analytics, staffing services, and facility operating revenue; those are adjacencies or substitutes that can influence budget allocation but are not interchangeable with the full LTPAC record system. A provider can also retain a status-quo mix of legacy software, manual work, and point integrations, so adoption requires migration, training, data governance, and confidence that the platform can meet regulatory reporting needs.[CM001, CM002, CM003, CM004]

2.2 Sizing through provider and workflow lenses

The evidence supports a bottom-up provider lens but not a defensible single TAM number. Definitive Healthcare tracks more than 18,400 active U.S. skilled nursing facilities and identifies nearly 1,900 parent organizations; its 2026 metro table gives 680 facilities in New York-Newark-Jersey City, 514 in Los Angeles-Long Beach-Anaheim, and 428 in Chicago-Naperville-Elgin. SNFData reports 16,858 facilities from each facility's most recent Medicare cost report, illustrating why differently scoped facility counts cannot be averaged or converted into software spend without a price-per-facility assumption. A third technographics lens identifies more than 1,602 companies using PointClickCare as an EHR tool in 2026, but detected companies are not interchangeable with facilities or provider organizations. PointClickCare materials separately claim more than 30,000 provider organizations and a 400-plus partner marketplace. These figures establish operating-unit and workflow lenses, not revenue, ARR, or obtainable share. SAM and SOM remain open until contract values, module penetration, renewal rates, and buyer segmentation are disclosed.[CM005, CM006, CM007, CM008, CM009]

2.3 Buyers, drivers, and constraints

The primary economic buyer is the skilled nursing or senior living operator, with finance and clinical leadership sharing budget ownership because the product affects both resident-care workflows and reimbursement administration. Users include nurses, clinicians, administrators, and care managers; external beneficiaries include hospitals, health plans, pharmacies, and analytics partners that depend on exchangeable records. Adoption is pulled by mandatory reporting, pressure to coordinate transitions, and value-based-care models that increasingly require measurable cost and quality performance. The Advisory Board's 2026 discussion says CMMI is emphasizing recognizable cost savings and downside risk, which increases the value of data integration but also raises the proof burden for technology vendors. Switching costs are correspondingly meaningful because a provider must migrate records, retrain staff, preserve billing continuity, and connect counterparties. Interoperability is also a constraint: the Real Time litigation shows that access controls, APIs, security protocols, and information-blocking rules can become commercial friction when analytics companies need data beyond the standard interface. This is a market driver and a material adoption risk, not proof that every buyer will expand spend.[CM010, CM011, CM012, CM013, CM014, CM015]

2.4 Evidence gaps

Public evidence does not isolate PointClickCare's current LTPAC software revenue, average contract value, module attach rate, net retention, customer concentration, or the share of the provider universe using competing systems. Published facility, organization, partner, patient, and detected- company counts use different units and cannot support a single penetration percentage. The litigation also leaves open how commercial API access, security exceptions, and partner economics will evolve. These gaps prevent a sourced SAM/SOM conversion and should be resolved with a segmented customer count, price book, cohort retention schedule, implementation funnel, competitive win-loss data, and documented interoperability economics. Until then, the defensible valuation lens is market structure and adoption friction rather than a precise top-down market value.[CM009, CM013, CM015, CM016]

2.5 Exhibits

3.1 Competitive landscape and buyer alternatives

The available evidence supports a segmented landscape rather than one interchangeable EHR category. PointClickCare is described as purpose-built for long-term and post-acute care, with admission, census, payer, room, transfer, discharge, billing, and coordination workflows. MatrixCare is the closest named LTPAC alternative in the assigned comparison sources, while WellSky and KanTime are framed around home-health needs. Epic, Oracle Health, MEDITECH, Veradigm, athenahealth, and eClinicalWorks are adjacent generalist choices whose broader acute or ambulatory scope does not by itself establish equivalent LTPAC depth. SeniorCRE represents a likely adjacent entrant in operator infrastructure, and Real Time demonstrates that analytics can sit above the system of record. Manual reports, exports, and customer-directed access remain status-quo substitutes. Public comparison pages are useful for class discovery, not market-share or outcome benchmarking.[CP001, CP002, CP003, CP004, CP005, CP015]

3.2 Capability, packaging, and buyer economics

Buying criteria should be normalized around care-setting fit, workflow coverage, interoperability, implementation burden, and total contract cost. Public pricing is particularly weak. Enzo, itself a competing home-health vendor, says PointClickCare uses custom quotes driven by organization size, modules, and care settings; its dollar ranges and competitor prices are explicitly third-party estimates, not vendor rate cards or realized customer contracts. The evidence therefore supports directional comparisons only. PointClickCare appears strongest for facility-centered buyers that value an integrated resident record and partner ecosystem. Home-health-only buyers have more specialized alternatives, while acute-care organizations can keep broader incumbent EHRs. Unsupported feature cells remain unknown because product-listing overlap is not proof of functional parity, and the assigned sources do not disclose competitor funding, retention, win rates, or normalized implementation economics.[CP001, CP002, CP003, CP004, CP005, CP006, CP007, CP008]

3.3 Moat durability, channel power, and adverse evidence

PointClickCare's moat is best understood as a combination of specialized workflow, installed distribution, and controlled integration rather than an unassailable feature lead. A company-issued release reports repeated KLAS recognition, more than 30,000 provider organizations, and over 400 integrated marketplace partners; a company appellate brief separately claims more than 30,000 healthcare providers and over 1.6 million patients. These issuer claims indicate scale but are not independent market-share measures. The same ecosystem creates tension over who controls data access. The Fourth Circuit summary and trade reporting describe an affirmed preliminary injunction in the Real Time dispute and likely information blocking, while PointClickCare argues that bot restrictions protect security, performance, and contractual controls. This conflict makes partner access a two-sided moat: governed APIs can reinforce retention and trust, but restrictive terms can provoke competitive, customer, and regulatory challenge. Durability should therefore be underwritten from actual contracts, API terms, migration rights, and customer references rather than awards or directory rankings alone.[CP009, CP010, CP011, CP012, CP013, CP014, CP016]

3.4 Exhibits

4.1 Revenue model and monetization

PointClickCare appears to monetize a modular cloud platform for long-term and post-acute care through custom enterprise contracts rather than a public self-serve rate card. Enzo's pricing review describes a subscription quoted by organization, with beds or census, module selection, and care settings driving the quote, and says facility contracts are commonly structured per bed per month (CI006, CI008). The same source gives third-party monthly estimates from $500-$2,000 for small organizations, $2,000-$5,000 for medium organizations, and $5,000-$15,000+ for large organizations, explicitly labeling these as estimates rather than vendor-published figures (CI007). This supports a recurring software-revenue model, not a verified ARR figure. The platform's stated scope includes clinical documentation, billing, care coordination, and compliance modules, so mix and realized price likely vary materially by setting and bundle; no source in this pool provides contracted price, discounting, renewal, or module-level revenue mix.[CI006, CI007, CI008, CI015]

4.2 Cost structure and operating leverage

The cost base is likely shaped by implementation, onboarding, training, data migration, integrations, and ongoing support in addition to product engineering and customer success. Enzo lists implementation and onboarding, recurring training, above-base support, custom interfaces, and data migration as costs to test separately from the subscription (CI009). It also suggests first-year total cost can run two to three times annualized subscription once setup, training, migration, and interfaces are included, but this is a category heuristic, not a PointClickCare disclosure (CI009). PointClickCare's scale proxy is meaningful: Growjo estimates 2,399 employees and $480.3M annual revenue, implying about $200,200 revenue per employee as its own estimate (CI001, CI004). That ratio is not a gross-margin or cash-generation measure. There is no public evidence here for gross margin, hosting cost, support cost per facility, CAC, sales cycle, payback, working capital, capex, or service-delivery cost, so operating leverage cannot be underwritten from the pool alone.[CI001, CI004, CI005, CI009]

4.3 Capital adequacy and financial verdict

Growjo estimates $230M of total funding and a current valuation of $4B, but those are third-party estimates and do not establish cash on hand, liquidity, proceeds remaining, debt, preferred terms, burn, or runway (CI002, CI003). The assigned evidence contains no cash balance, debt schedule, financing covenant, next-round trigger, or planned use of funds. It therefore cannot support a capital-adequacy conclusion or a precise valuation multiple. Commercial scale may be substantial: Taction, an integration provider, describes 27,000+ LTC/PAC providers and 3,100+ hospitals, while Healthcare IT Today reports the company said more than 1.2 million professionals access the platform daily and that it serves approximately 1.6 million patients; these are company or partner-reported traction figures, not audited revenue evidence (CI015, CI014). The adverse legal record also shows that PointClickCare characterized automated access as a risk of slowdowns or outages for paying customers, while the Fourth Circuit affirmed a preliminary injunction finding likely information blocking (CI011, CI012). This creates potential compliance, platform-governance, and partner-economics exposure that should be reflected in underwriting rather than treated as a settled financial loss.[CI002, CI003, CI011, CI012, CI014, CI015]

4.4 Exhibits

5.1 Product surface and customer workflow

PointClickCare is delivered as a cloud-based electronic health record and operating platform for long-term and post-acute care. The public product descriptions place the system in the daily workflow of skilled nursing, senior-living, and related post-acute providers: clinical documentation, assessments, care plans, medication administration, billing, claims, analytics, and care transitions are represented as modules or connected services rather than as a single point solution. The independent API profile identifies a partner EHR API and an HL7 FHIR API, with a developer portal and REST base URL, which is concrete evidence of a programmatic interoperability surface rather than merely a marketing claim. IntuitionLabs describes the platform as a cloud-delivered, multi-tenant system of record, while cautioning that product pages do not establish every clinical capability; for example, QuickMAR documentation supports medication administration and pharmacy-connected workflows but does not establish prescribing authority. The resulting product thesis is breadth and workflow centrality, with diligence focused on the exact licensed modules, data scopes, implementation effort, and realized customer outcomes.[CE001, CE002, CE003, CE004]

5.2 Architecture, integrations, and maturity

The public architecture is best understood as a layered SaaS operating model. A shared cloud application layer supports a logical separation of customer data, while domain modules handle clinical records, medication administration, revenue-cycle work, analytics, and resident or family engagement. External connectivity is a strategic layer: PointClickCare exposes APIs and FHIR-oriented interoperability, and the broader platform has been extended through care-coordination and network assets. This structure can reduce duplicate entry and make the product more valuable as a facility adds workflows, but it also creates dependency on interface contracts, partner permissions, data mapping, and reliable change control. The current maturity signal is mixed by feature. Core EHR and RCM functions are described as established workflows; the June 2026 Advisor release says Billing Advisor is available to all skilled nursing providers using the PointClickCare EHR, while MDS Advisor was described as beta for 2026. That distinction matters: announced, generally available, beta, and planned capabilities should not be treated as equivalent deployment maturity. The product architecture is therefore credible as a broad platform, but module-level availability, integration test evidence, uptime history, and migration controls remain customer-specific diligence items.[CE005, CE006, CE007, CE008]

5.3 Trust, safety, and technical risk

PointClickCare operates in a high-consequence data environment where confidentiality, availability, and permitted use of electronic health information are product requirements, not optional add-ons. The strongest adverse evidence is the Real Time Medical Systems dispute. The Fourth Circuit summary says the district court found PointClickCare's access restrictions likely constituted information blocking and that PointClickCare did not demonstrate that an exception applied; the independent legal analysis further reports that the court viewed the security and performance rationale as insufficiently documented and not shown to be consistently applied. McKnight's account records PointClickCare's contrary position that automated bots could cause slowdowns or outages and that customer agreements prohibit screen scraping. These are competing positions in ongoing litigation, not proof that the platform is insecure or that every access control is unlawful. They do show a technical-governance risk: platform security controls, partner authentication, API coverage, bot policy, exception documentation, and customer data rights must be designed and evidenced together. The product review should therefore request current security attestations, incident and uptime history, interface inventories, access-control standards, and the documented process for handling legitimate third-party analytics access.[CE009, CE010, CE011, CE012]

5.4 Exhibits

6.1 Customer base and buying surfaces

PointClickCare sells into a multi-sided care-delivery workflow rather than a single software persona. The platform is described as serving skilled nursing, senior living, hospice, and related post-acute organizations, with nurses, managers, physicians, administrators, revenue-cycle teams, and external partners as users. An assigned customer database identifies Avamere, Select Rehabilitation, Continuing Healthcare Solutions, Carespring Healthcare Management, and Allied Services as organizations using the EHR, while the case-study directory lists named technology and operations users at PointClickCare itself. These sources establish segment breadth and workflow relevance, not a current audited customer count or revenue split. The strongest commercial signal is system-of-record behavior: named deployments cover admissions, discharges, bed transfers, medication administration, behavioral-health charting, hospice intake, and interdisciplinary care. That breadth can support multi-module adoption, but the assigned evidence does not quantify module attach rates, pricing, renewal terms, or revenue by segment.[CU001, CU002, CU003, CU004, CU005]

6.2 Adoption breadth, trajectory, and durability

Adoption evidence points to substantial scale, but the measures are not interchangeable. A 2026 company-issued release says PointClickCare is trusted by over 30,000 provider organizations and has a marketplace of more than 400 integrated partners; an independent technology guide separately discusses a vendor-reported figure of more than 60% of U.S. skilled nursing facilities and distinguishes that from older filing snapshots. The same guide records historical 2015 figures of approximately 2,300 customer organizations, 10,900 facilities, and roughly 850,000 residents served per day, explicitly labeling them historical. These datapoints support a large installed base and broad workflow penetration, but they do not form a time-series cohort. There is no assigned source with current NRR, GRR, churn, renewal rates, contract length, or customer-level expansion. Durability is therefore inferred from workflow centrality and multi-facility use, not presented as measured retention.[CU006, CU007, CU008, CU009, CU010]

6.3 Named customer proof, expansion, and concentration risk

Named customer evidence is concrete on use cases but uneven on outcome measurement. Apps Run The World describes Allied Services using PointClickCare for admissions, discharges, bed transfers, and cross-EMR automation; Avamere deployments for clinical, medication, behavioral-health, wound-care, and hospice workflows; and Bella Care Hospice for admissions, consent, recertification, care planning, scheduling, and interdisciplinary meetings. A separate customer-story directory lists customer testimonials and outcomes such as reduced certification time, HIPAA-compliant analytics and disaster recovery, and improved care transitions, but does not provide a standardized denominator or audited counterfactual. The assigned adverse evidence adds a durability risk: the Fourth Circuit affirmed a preliminary injunction after finding PointClickCare likely engaged in information blocking in a dispute over third-party automated access, while PointClickCare argued bots could create slowdowns or outages. This does not prove customer churn, but it makes interoperability and partner-access governance a customer-retention variable. Current top-customer concentration, pilot-to-production conversion, and outcome persistence remain open.[CU011, CU012, CU013, CU014, CU015]

6.4 Exhibits

7.1 Legal and regulatory exposure

The Real Time Medical Systems dispute is the most concrete company-specific risk in the assigned evidence. The Fourth Circuit affirmed a preliminary injunction for Real Time and agreed that PointClickCare's actions likely violated the Cures Act's information-blocking prohibition; this was a preliminary assessment, not a final merits disposition. As of June 10, 2025, McKnight's reported that PointClickCare had renewed its motion to dismiss while the injunction remained in place. The court's treatment of PointClickCare's manner, security, and health-IT-performance defenses makes documentation quality, consistent enforcement, and alternate data-access coverage central control tests. The case also creates a broader pathway for alleged Cures Act violations to support Maryland unfair-competition claims even though the federal statute itself has no private right of action.[CR001, CR002, CR003, CR004, CR014]

7.2 Operational resilience and patient-data security

Platform availability and data integrity have unusually high consequences because PointClickCare's own appellate brief described more than 30,000 provider organizations and over 1.6 million patients using the platform. The same brief alleged one bot-related system collapse affecting 10,000 patients and a separate latency incident affecting 7,700 patients, but those figures are litigant assertions rather than independently verified incidents. A Documo partner article describes encryption, individual credentials, business-associate agreements, and physical, technical, and administrative safeguards; it is not an independent control attestation. Sector evidence raises the baseline threat: HIPAA Journal reported that hacking and other IT incidents accounted for more than 80% of large healthcare breaches in 2025, while DeXpose describes third-party and supply-chain compromise as rivaling direct attacks.[CR007, CR008, CR009, CR010, CR011, CR012]

7.3 Partner, workflow, and model dependencies

PointClickCare's data ecosystem is both a moat and a control surface. McKnight's reported the company's statement that roughly 1,900 other data partners followed specified security protocols and paid a reasonable access rate, but the assigned evidence does not independently reconcile that population, its concentration, or the commercial terms. The Real Time dispute demonstrates how access method, API coverage, bot restrictions, and price can migrate from partner negotiation into litigation and reputational exposure. Third-party descriptions also make clear that cross-continuum data exchange and integrated workflows are core to the product proposition, so a failure in an access path can affect customer operations rather than merely an optional add-on. Public custom-pricing descriptions leave implementation and margin sensitivity unquantified.[CR006, CR012, CR013]

7.4 Residual risk, mitigations, and thesis-break triggers

Legal and access-governance exposure ranks highest because it is supported by an affirmed preliminary injunction, continuing litigation, and judicial skepticism toward the evidence then offered for PointClickCare's exceptions. Cyber and continuity risk ranks next because the platform's asserted scale magnifies harm, while public evidence does not establish current recovery performance or independent control effectiveness. Mitigation should be judged through the live case docket, exception memoranda, consistent access-control logs, API completeness, SOC or HITRUST evidence, incident and recovery testing, partner concentration, and insurance coverage. Thesis-break triggers are a final adverse information-blocking outcome that constrains the operating model, a material patient-data or availability event, repeated inability to support access restrictions with documented evidence, or losses and remediation costs that exceed verified insurance and liquidity capacity.[CR001, CR003, CR004, CR007, CR010, CR011, CR015, CR016]

7.5 Exhibits

8.1 Investment call and valuation anchor

The evidence supports a research-more recommendation with medium confidence and high risk, rather than a price-insensitive buy. Tracxn reports $283M of cumulative funding across five rounds and a $4B valuation dated January 6, 2021. That is a historical third-party marker, not evidence of a current financing price. Sacra's much thinner fetched profile displays $86.91M under "Funding" alongside 2024 without defining the denominator, illustrating why public financing aggregations cannot substitute for primary transaction documents. The assigned sources provide no verified current revenue or ARR denominator, so neither a current enterprise value nor an entry multiple can be calculated responsibly. A buyer should require a current financing document, audited recurring-revenue bridge, cohort retention, and the cap-table and preference waterfall before underwriting a secondary purchase.[CV001, CV002, CV004, CV014, CV015, CV016]

8.2 Thesis, anti-thesis, and price sensitivity

The thesis is that PointClickCare occupies a specialized, regulated workflow where a cloud-based EHR can become a durable system of record. ResearchOrg describes the company as bringing cloud EHR technology to a long-term and post-acute market underserved by legacy on-premise systems, while Tracxn ranks it first in its six-company active-competitor set. PointClickCare's own appellate brief claims more than 30,000 healthcare-provider users and more than 1.6 million patients; those figures demonstrate the company's asserted scale but remain company-issued litigation evidence, not independent verification. The anti-thesis is that platform centrality creates interoperability and regulatory exposure. The Fourth Circuit affirmed a preliminary injunction in the Real Time dispute, and the current status after the June 2025 reporting is not established by the assigned pool. The recommendation should improve only after scale, retention, margins, and the legal remedy are independently verified.[CV003, CV005, CV006, CV007, CV008, CV009, CV013]

8.3 Scenarios and comparable valuation framework

A revenue-multiple framework is the least-worst public benchmark until PointClickCare's profitability and cash generation are disclosed, but it cannot produce a dollar valuation without a verified denominator. Aventis reports a 4.6x median public SaaS EV/revenue multiple as of August 2026 and a 3.1x median for the explicitly small first-quarter 2026 private SaaS M&A sample. A separate independent reference describes healthtech SaaS as spanning roughly 1x to 7x, showing that vertical labels alone do not select a multiple. The scenario bands therefore segment those observed reference points rather than assert a PointClickCare value: the bear case uses 1.0x-3.1x revenue, the base case 3.1x-4.6x, and the bull case 4.6x-7.0x. Growth, NRR, gross margin, cash conversion, recurring-revenue purity, private-company illiquidity, dilution, and the legal outcome must determine where within or outside those reference bands the company belongs.[CV010, CV011, CV012, CV016]

8.4 Diligence asks, exit readiness, and thesis breaks

Public evidence is not sufficient to establish exit readiness or a target return. Before committing capital, obtain audited 2024-2026 revenue and ARR bridges, bookings, churn and NRR cohorts, gross-margin and free-cash-flow statements, debt, option dilution, liquidation preferences, secondary-transfer terms, and a current legal-status memorandum for the Real Time matter. The investment thesis should break if verified retention is materially weaker than the platform narrative, margins or cash conversion require unmodeled capital, a financing below the historical marker exposes preference overhang, or a legal remedy makes compliant data access commercially unattractive. Positive movement requires primary evidence of durable expansion, improving profitability, a clean preference waterfall, and a documented access model that customers, partners, and regulators can sustain. Until then, the appropriate exit assumption is unproven rather than an invented IPO timetable or return multiple.[CV007, CV008, CV009, CV015, CV016]

8.5 Exhibits